摘要
Recent studies have shown that statins can influence insulin resistance （IR） in animal models and inhumans.1.2 However, the mechanism by which statins influence the insulin signaling pathway （ISP） remains obscure. It has been proposed that the pleiotropic effects of statins might be involved in regulation of IR.The phosphatidylinositol 3-kinase （PI3K）-Akt/protein kinase B （PKB） pathway is the main ISE Insulin binding to insulin receptor initiates PI3K-Akt pathway by phosphorylates tyrosine residue of IR substrate proteins （IRSs） including IRS-1 and IRS-2. Activation of the PI3K leads to the accumulation of phosphatidylinositol 3,4,5-triphosphate （PIP3）. PIP3 activates serine/ threonine kinase （Akt）. Glucose transporter-4 （GLUT-4） translocates to plasma membrane from cytosol by serine phosphorylation of Akt and directly regulates glucose metabolism in liver, muscle and adipose tissue （Figure 1）. However, an overall mechanism by which statins influence ISP remained obscure.
Recent studies have shown that statins can influence insulin resistance （IR） in animal models and inhumans.1.2 However, the mechanism by which statins influence the insulin signaling pathway （ISP） remains obscure. It has been proposed that the pleiotropic effects of statins might be involved in regulation of IR.The phosphatidylinositol 3-kinase （PI3K）-Akt/protein kinase B （PKB） pathway is the main ISE Insulin binding to insulin receptor initiates PI3K-Akt pathway by phosphorylates tyrosine residue of IR substrate proteins （IRSs） including IRS-1 and IRS-2. Activation of the PI3K leads to the accumulation of phosphatidylinositol 3,4,5-triphosphate （PIP3）. PIP3 activates serine/ threonine kinase （Akt）. Glucose transporter-4 （GLUT-4） translocates to plasma membrane from cytosol by serine phosphorylation of Akt and directly regulates glucose metabolism in liver, muscle and adipose tissue （Figure 1）. However, an overall mechanism by which statins influence ISP remained obscure.
